InvestorsHub Logo

djmurdock

12/22/16 12:13 PM

#329 RE: a surfer #328

Yeah, some good points in this article too:

http://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Starts+Zynerba+Pharmaceuticals+(ZYNE)+at+Overweight/12364738.html

"We believe success in the refractory epilepsy program is strongly supported by recent oral CBD data in orphan pediatric epilepsies achieved by GW Pharmaceuticals (GWPH – Overweight). Furthermore, the delivery of CBD through the skin, avoiding first pass metabolism by the liver, could represent a significant advantage, in our view"

stocky101

12/23/16 10:09 AM

#332 RE: a surfer #328

Def my new pic, could be $200 stock a year from now